FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine
Committee recommends emergency use authorization of the vaccine; vaccine to be distributed within 24 hours of EUA
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.